A deuterated analog of dasatinib disrupts cell cycle progression and displays anti‐non‐small cell lung cancer activity <i>in vitro</i> and <i>in vivo</i>

Chunhua Ling(Soochow University), Xinliang Mao(Guangzhou University of Chinese Medicine)
International Journal of Cancer
February 23, 2012
Cited by 28


Related Papers